Mode
Text Size
Log in / Sign up

Favorable adiposity, statins, vitamin D, dried fruit linked to lower ovarian cancer risk in MR meta-analysisGenetic study links vitamin D, statins to lower ovarian cancer risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret these MR findings as genetic associations, not causal evidence; do not infer clinical benefit from statins or vitamin D supplementation.

This systematic review and meta-analysis of Mendelian randomization (MR) studies examined the genetic evidence linking various exposures to ovarian cancer risk. The analysis pooled data from multiple MR studies to assess associations between genetically predicted exposures and ovarian cancer.

Key findings include a protective association for favorable adiposity (OR per SD 0.35, 95% CI 0.20-0.61), HMG-CoA reductase inhibitor genetic proxies (OR 0.66, 95% CI 0.53-0.82), serum vitamin D (OR 0.88, 95% CI 0.82-0.95), and dried fruit intake (HR 0.61, 95% CI 0.41-0.91). These associations were all in the direction of lower ovarian cancer risk.

The authors note that while genetic evidence supports these associations, causality is not definitively established. The associations between vitamin D and HMG-CoA reductase inhibition with ovarian cancer risk warrant further study. Importantly, these findings should not be interpreted as evidence that statins or vitamin D supplementation reduce ovarian cancer risk, as only genetic proxy associations were reported. No clinical recommendations can be made from this genetic evidence alone.

A new analysis of genetic studies suggests that higher vitamin D levels, using statins (HMG-CoA reductase inhibitors), and eating dried fruit may be linked to a lower risk of ovarian cancer. The research also found that having a favorable body fat profile was associated with a 65% lower risk. However, these findings come from genetic data, not from clinical trials, so they do not prove cause and effect.

The study combined results from multiple Mendelian randomization studies, which use genetic variants to mimic the effects of an exposure. This approach can help identify potential risk factors, but it has limitations. The researchers caution that the associations for vitamin D and statins need further study before any recommendations can be made.

Importantly, this does not mean that taking vitamin D supplements or statins will prevent ovarian cancer. The evidence is based on genetic proxies, not on actual treatments. No safety concerns were reported in this analysis, but that does not mean these interventions are risk-free.

For now, the best advice remains to follow a healthy lifestyle and discuss any concerns about ovarian cancer risk with a doctor. This study adds to the scientific conversation but is not a reason to change your current health habits.

What this means for you:
Genetic links exist, but don't change your diet or medications based on this alone.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Ovarian cancer (OC) remains a major global health issue, often diagnosed late and lacking effective screening. METHODS: MR studies until 11 September 2023 were identified by a systematic search across nine databases. We complied with PRISMA guidelines and included different OC subtypes and all exposures studied, conducting meta-analyses where feasible to combine estimates from non-overlapping samples. RESULTS: We identified 120 articles examining genetic evidence for an association between 230 exposures and OC risk. Endometriosis, late age at menopause, and several adiposity measures were robustly associated with greater OC risk. In contrast, late age at menarche, higher adiponectin, and body fat without adverse metabolic profile were associated with lower risk (favourable adiposity: meta-analysis OR per SD 0.35, 95% CI 0.20-0.61). Meta-analyses on lipid-lowering drug target HMG-CoA reductase inhibitor (OR 0.66, 95% CI 0.53-0.82), serum vitamin D (OR 0.88, 95% CI 0.82-0.95), and dried fruit intake (HR 0.61, 95% CI 0.41-0.91) were supportive of protective associations. CONCLUSIONS: Genetic evidence confirms OC risks associated with endometriosis, and age at menarche and menopause. While greater overall adiposity increases the risk, fat without an adverse metabolic profile appears protective. Associations between vitamin D and HMG-CoA reductase inhibition with OC risk warrant further study.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.